An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

计划入组 4,785 人 · 首次发布于 2022 年 7 月 18 日

Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

计划入组 30 人 · 首次发布于 2014 年 5 月 16 日

Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

计划入组 60 人 · 首次发布于 2015 年 7 月 22 日

amlodipine besylate;losartan potassium;rosuvastatin calcium

OpRegen-Plus

Euvichol-Plus

OXYPROS PLUS

United States

Plus Therapeutics

United States

Bumpers Plus

United States

Hanmi Pharm Seeks Approval for Triple-Combination Hypertension Drug Amosartan PLUS-L

Hanmi's Gugutams Launches in Mexico as Aditams: First Dual OPG-ED Combination Therapy Enters Latin American Market

Talazoparib Plus Enzalutamide Demonstrates Superior Outcomes in mCRPC Compared to Other PARP Inhibitor Combinations